Shanghai Fosun Pharmaceutical (Fosun Pharma), a China-based healthcare group, and Insilico Medicine, a US-based artificial intelligence (AI)-driven drug discovery and development company, announced on Jan.
Read more: https://bit.ly/3KgMMKF
✎ 創業與自由 ✎
Shanghai Fosun Pharmaceutical (Fosun Pharma), a China-based healthcare group, and Insilico Medicine, a US-based artificial intelligence (AI)-driven drug discovery and development company, announced on Jan.
Read more: https://bit.ly/3KgMMKF
Here’s what you need to know today in startup and venture news, updated by the Crunchbase News staff throughout the day to keep you in the know. Insilico Medicine, a developer of AI-enabled tools for drug discovery, raised $255 million in a Series C funding round.
Read more: https://bit.ly/3jjiCLV
Proudly powered by WordPress | Theme: Baskerville 2 by Anders Noren.